Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caplice
Simari

Showing results (1-10 of 375) with videos related to

Pageof 38
Sort By:
Current Interventional Cardiology Reports|November 30, 2000
Gene Transfer for Coronary RestenosisCaplice, Simari
International Journal of Cardiovascular Interventions|March 8, 2003
Molecular biology and gene transfer in atherosclerosis in the stenting eraNoel M Caplice, Robert D Simari, David R Holmes
Circulation|September 16, 1998
Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activityN M Caplice, C S Mueske, L S Kleppe, et al.
International Angiology : a Journal of the International Union of Angiology|December 16, 2005
TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complicationsG Novo, N Caplice, R Tantillo, et al.
Thrombosis and Haemostasis|October 5, 2001
Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitorP G Stalboerger, C J Panetta, R D Simari, et al.
Atherosclerosis|December 2, 1999
Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemiaS H Wilson, N M Caplice, R D Simari, et al.
Biochemical and Biophysical Research Communications|December 22, 1999
The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cellsT E Peterson, L S Kleppe, N M Caplice, et al.
Circulation Research|December 16, 1998
Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factorsN M Caplice, C S Mueske, L S Kleppe, et al.
Current Interventional Cardiology Reports|November 30, 2000
The Artificial ArteryCaplice
Human Gene Therapy|February 28, 2002
A tissue-engineered stent for cell-based vascular gene transferCarmelo J Panetta, Katsumi Miyauchi, David Berry, et al.
Pageof 38

Showing results (1-10 of 375) with videos related to

Sort By:
Pageof 38
Current Interventional Cardiology Reports|November 30, 2000
Gene Transfer for Coronary RestenosisCaplice, Simari
International Journal of Cardiovascular Interventions|March 8, 2003
Molecular biology and gene transfer in atherosclerosis in the stenting eraNoel M Caplice, Robert D Simari, David R Holmes
Circulation|September 16, 1998
Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activityN M Caplice, C S Mueske, L S Kleppe, et al.
International Angiology : a Journal of the International Union of Angiology|December 16, 2005
TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complicationsG Novo, N Caplice, R Tantillo, et al.
Thrombosis and Haemostasis|October 5, 2001
Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitorP G Stalboerger, C J Panetta, R D Simari, et al.
Atherosclerosis|December 2, 1999
Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemiaS H Wilson, N M Caplice, R D Simari, et al.
Biochemical and Biophysical Research Communications|December 22, 1999
The regulation of caveolin expression and localization by serum and heparin in vascular smooth muscle cellsT E Peterson, L S Kleppe, N M Caplice, et al.
Circulation Research|December 16, 1998
Expression of tissue factor pathway inhibitor in vascular smooth muscle cells and its regulation by growth factorsN M Caplice, C S Mueske, L S Kleppe, et al.
Current Interventional Cardiology Reports|November 30, 2000
The Artificial ArteryCaplice
Human Gene Therapy|February 28, 2002
A tissue-engineered stent for cell-based vascular gene transferCarmelo J Panetta, Katsumi Miyauchi, David Berry, et al.
Pageof 38